Category: Providers

Apotex to Issue Refunds to 340B Covered Entities

July 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.

A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

July 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.

Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Texas Hospitals Ask Judge to Block HHS’ DSH Calculation Rule That Impacts 340B Eligibility

July 9, 2024 Bella Czajkowski, National Correspondent Views

A group of Texas hospitals urged a federal court to grant their request for a summary judgement—or at minimum preliminary relief—in a case challenging an HHS rule.

A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Coalition Conference Keynote: Program Faces ‘Progress Amid Challenges’

July 8, 2024 William Newton, Associate Editor/Senior Writer Views

Maureen Testoni, president and CEO of 340B Health, gave a keynote "state of 340B" address July 8 at the 340B Coalition summer conference.

The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Missouri GOP Lawmaker Slams State AG’s ‘Irresponsible’ Claims Linking 340B Bill to Abortion As Governor’s Decision Looms

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Missouri Attorney General Andrew Bailey (R) was rebuked by a GOP state lawmaker for linking a state 340B contract pharmacy bill to abortion.

Missouri Gov. Mike Parson (R) has less than two weeks to decide the fate of a 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Viatris Becomes 37th Manufacturer to Place Restrictions on 340B Contract Pharmacy Use; Policy Applies to Hospitals and Health Centers

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Drug manufacturer Viatris has placed 340B contract pharmacy restrictions on hospitals and community health centers.

Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

July 2, 2024 Shannon Young, Associate Editor/Senior Writer Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Just Days Before New Laws Go Into Effect, GSK, Pfizer Exempt Additional States from Contract Pharmacy Restrictions

June 27, 2024 Shannon Young, Associate Editor/Senior Writer Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Fear ‘Collateral Damage’ From New Manufacturer Restrictions on Wholly-Owned Pharmacies

June 27, 2024 William Newton, Associate Editor/Senior Writer Views

Ohio-based Signature Health will lose 340B drug access at its fully owned central fill pharmacy as a result of five new drugmaker policies.

Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live